SCHEMBL10151409

SCHEMBL10151409

COc1ccc2nc(CF)n(-c3cnc(NC(=O)c4snnc4C)cn3)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
CRACR2A Q9BSW2 1/20 0.36
LMNA P02545 1/20 0.36
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
POLB P06746 2/20 0.35
GRM5 P41594 1/20 0.35
KDM4E B2RXH2 2/20 0.34
USP2 O75604 1/20 0.34
NPC1 O15118 1/20 0.34
MITF O75030 1/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
RAB9A P51151 1/20 0.34
BMI1 P35226 2/20 0.33
TRPC3 Q13507 1/20 0.33
ORAI1 Q96D31 1/20 0.33
TRPC5 Q9UL62 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL645672 0.87 CRACR2A (0.41) ALDH1A1CRACR2ALMNAPOLBGRM5
SCHEMBL10151287 0.83 BMI1 (0.34) LMNAKDM4ENPC1TP53GAA
SCHEMBL10151672 0.82 RAB9A (0.44) POLBGRM5KDM4ENPC1RAB9A
SCHEMBL10151674 0.82 TP53 (0.38) LMNAPOLBGRM5KDM4EUSP2
SCHEMBL646789 0.81 CRACR2A (0.41) ALDH1A1CRACR2ALMNAPOLBGRM5
SCHEMBL10151390 0.76 RAB9A (0.42) ALDH1A1POLBKDM4ENPC1MITF
SCHEMBL646772 0.75 CRACR2A (0.40) ALDH1A1CRACR2ALMNAPOLBNPC1
SCHEMBL10151385 0.73 NPC1 (0.36) ALDH1A1GRM5KDM4ENPC1MITF
SCHEMBL645712 0.73 POLB (0.41) ALDH1A1CRACR2ALMNAPOLBKDM4E
SCHEMBL10151679 0.72 STIM1 (0.37) LMNANPC1TP53GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119643-B2 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2012-02-21 US disclosed